ANDE Corp

LONGMONT, CO · CIK 0001689723 · Medtech · Private

Rapid DNA identification system that generates forensic DNA profiles in less than 2 hours

ande.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$109M
5 Form D · Apr 2020
78 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$16,911,660
Private capital raisedForm D · SEC$15,999,762
Private capital raisedForm D · SEC$25,498,617
Private capital raisedForm D · SEC$31,007,256
Private capital raisedForm D · SEC$19,751,643
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1731Sera Prognostics—$150M
1732Trevi Therapeutics, Inc.—$118M
1733EPOULOSIS THERAPEUTICS, INC.——
1734ANDE Corp—$109M
1735PAIGE.AI, Inc.—$108M
1736EKSO BIONICS HOLDINGS, INC.—$103M
1737BEAM - CA, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Edward DavisDirector
  • George HeinrichsDirector · Executive Officer
  • Beth KronfeldDirector
  • David KronfeldDirector
  • Paul MatsudairaDirector
  • Susan O'KeefeExecutive Officer
  • John RoseExecutive Officer
  • Richard SeldenDirector · Executive Officer
  • Starnes WalkerDirector

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.